Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
27 feb 2025
Mrkt BUZZ InCoax Q4 2024: Delayed order lead to weak Q4 2024 results
Equity Research
InCoax
27 feb 2025
Equity Research Svenska Aerogel, Q4 2024: Higher than expected revenues and rights issue
Equity Research
Svenska Aerogel
27 feb 2025
Equity research, Zinzino Q4 2024: First impression
Equity Research
Zinzino
26 feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Equity Research
Immunovia
25 feb 2025
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
Equity Research
Teneo AI
24 feb 2025
Equity Research ALM Equity, Q4 2024: The market situation is about to improve
Equity Research
ALM Equity
20 feb 2025
Equity research Viva Wine Group, Q4 2024: Positive growth momentum should continue
Equity Research
Viva Wine Group
20 feb 2025
Equity Research GIAB: Healthy core business risks reconstruction
Equity Research
20 feb 2025
Equity research Nosa Plugs Q4, 2024: Strong growth and announced M&A strategy
Equity Research
Nosa Plugs
20 feb 2025
Equity Research ALM Equity, Q4 2024: Stronger finances and an improved market
Equity Research
ALM Equity
20 feb 2025
Equity research Viva Wine Group, Q4 2024: First impression
Equity Research
Viva Wine Group
17 feb 2025
Equity Research Ecoclime Q4 2024: Improvement expected in 2025
Equity Research
17 feb 2025
Equity Research KlaraBo, Q4 2024: Higher rent increases property value
Equity Research
KlaraBo
16 feb 2025
Equity research CDON AB, Q4 2024: A mixed bag and room for improvement
Equity Research
CDON
14 feb 2025
Equity research Zinzino: Significant expansion of US business
Equity Research
Zinzino
14 feb 2025
Equity Research Ecoclime, Q4 2024: Weak quarter, but expected to improve in 2025
Equity Research
14 feb 2025
Equity Research KlaraBo, Q4 2024: Better management results and large property value gains
Equity Research
KlaraBo
14 feb 2025
Equity Research Nosa Plugs: First impression Q4, 2024
Equity Research
Nosa Plugs
13 feb 2025
Equity research CDON Q4 2024: First impression
Equity Research
CDON
13 feb 2025
Equity Research GIAB, Q4 2024: Lack of liquidity due to weak sales
Equity Research
1
…
7
8
9
10
11
…
64